Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-16

Clinical Trial Update: Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the correlation between serum perampanel levels and cerebrospinal fluid levels in epilepsy/seizures patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perampanel (perampanel)

Snippet

Sponsor: Carilion Clinic | Conditions: Epilepsy, Seizures | Phase 4 | Status: UNKNOWN